Navigation Links
ESMO in Medical News

ECCO 15 -- ESMO 34 multidisciplinary cancer congress

ECCO 15 ESMO 34 will take place at the ICC Berlin Internationales Congress Centrum, Messedamm 22, D-14055 Berlin, Germany ( www.icc-berlin.de ) from Sunday 20 September to Thursday 24 September 2009. ECCO 15 ESMO 34 will build on the success of the previous ECCO (European Cancer Conference) ...

2nd ESMO symposium on soft tissue carcinomas and GIST

Experts in treating a rare group of cancers that affect tissues such as muscle, fat, nerves and the gastrointestinal wall are meeting in Milan, Italy on 13-14 May to discuss the latest information on how these diseases develop and potential new avenues for therapy. The 2nd Symposium on Sarcoma ...

Handbook of cancer prevention launched by ESMO

A new publication designed to help individuals, doctors and governments reduce the global burden of cancer has been announced today by Europes leading society for medical oncologists. The ESMO Handbook of Cancer Prevention, from the European Society for Medical Oncology, contains state-of-the-a...

Transatlantic alliance supports breast cancer research

...n translational research will discuss cutting-edge treatments that are now moving from laboratories into the clinical setting. Komen will also support esmo research fellowships in preeminent cancer centers in Western Europe to offer doctors from Eastern European countries the opportunity to learn the newe...

New data on link between cancer and nutrition discussed at European symposium

.... The latest research findings on these topics will be discussed at the esmo Symposium on Cancer and Nutrition (20-21 March 2009), organized by the Euro...the advice given to people is based on proper scientific evidence." The esmo Symposium will discuss the latest evidence on the link between diet and can...

GlaxoSmithKline and Genmab Submit Arzerra(TM) (Ofatumumab) Application to FDA for the Treatment of Advanced Stage Blood Cancer

...ures 2008. http://www.cancer.org/downloads/STT/2008CAFFfinalsecured.pdf . Accessed January 28, 2009. (2) Eichhorst B. Chronic lymphocytic leukemia: esmo Clinical Recommendations for diagnosis, treatment and follow-up. Ann Oncol 2008. 19:60-62. doi:10.1093/annonc/mdn090. (3) Leukemia and Lymphoma Soci...

Get the latest on premier science in medical oncology

...reate lively discussions on hot topics. The 7th esmo Patient Seminar where patients will have the chanc...t state-of-the-art oncology. The fifth batch of esmo Designated Centers of Integrated Oncology and Pall...llence for patient care in Europe. A session on esmo Clinical Recommendations will update current...

10th World Congress on Gastrointestinal Cancer -- Barcelona, Spain

... As it celebrates its 10th year, the esmo International Symposium: 10th World Congress on Gastrointestinal Cancer has...g the medical community and look forward to continuing the journey." The esmo International Symposium: 10th World Congress on Gastrointestinal Cancer, de...

Symposium focuses on curable cancer that affects young men

...e adopted course," Prof. Schmoll continued. The esmo Symposium on Testicular Cancer will present cuttin...eeting, the Symposium Faculty will convene for the esmo International Consensus meeting on Testicular Tumo...al important topics in the field and to update the esmo Clinical Recommendations (CR) on Testicular semino...

European Society for Medical Oncology and European CanCer Organization join forces

...n-numbered years between the ECCO-ESMO congresses, esmo will continue to hold its own esmo Congress. In 2008, the 33rd esmo Congress will take place as planned, 12-16 Septemb...
ESMO in Medical Technology

Micromet Presents Data at ESMO 2008 on Anti-EpCAM Antibody Adecatumumab (MT201) in Combination with Chemotherapy

Interim data from Phase 1b Study indicate that adecatumumab in combination with docetaxel is safe and well tolerated and suggest a better outcome for breast cancer patients with high EpCAM expression BETHESDA, Md., Sept. 15 /PRNewswire-FirstCall/ -- Micromet, Inc. (Nasdaq: MITI ), a...

Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference

LOS ANGELES--(BUSINESS WIRE)--July 8, 2007 - Cougar Biotechnology, Inc. (OTCBB:CGRB) today announced that positive Phase I and Phase II data on the Company's prostate cancer drug candidate CB7630 (abiraterone acetate) were presented at the European Society for Medical Oncology (ESMO) Conference, wh...

YM BIOSCIENCES ANNOUNCES NIMOTUZUMAB PRESENTATIONS TO BE MADE AT THE 100TH ANNUAL MEETING OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH AND EUROPEAN SOCIETY FOR MEDICAL ONCOLOGY

...; Session ID: Clinical Research 10). The abstract of this poster has been published today (09-AB-5492-AACR). "Data to be presented at the AACR and esmo conferences, combined with rash being reported independent of the KRAS status of patients, are in sharp contrast to the dated speculation that toxicit...

Medarex Announces Presentations at the 33rd Congress of the European Society for Medical Oncology

...ct #768O) V. Chiarion Sileni - Oral presentation from 3:30 p.m. to 5:30 p.m. local time on Monday, September 15, 2008. More information about the esmo Congress may be found at http://www.esmo.org . About Medarex Medarex is a biopharmaceutical company focused on the discovery, development and pote...

European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGene's Cancer-Killing Virus in Press Conference

...e I/II trial of oncolytic HSV * Poster selected by esmo for presentation in press conference MARTINSRIED...take place on Friday, July 6, at 12:30 MEST at the esmo conference in Lugano, Switzerland (ECLU). Dr. Axel...nalysis of this study. The poster presented at the esmo conference shows efficacy data in a case study for...

MediGene Announces Cancer-Fighting Virus Shows Promise in Early Clinical Trial

...a preliminary study, researchers said today at the esmo Conference Lugano (ECLU), Switzerland. The virus...ltidisciplinary cancer treatment around the world. esmo unites medical oncologists, oncology specialists, ... state-of-the-art education and training programs, esmo plays an instrumental role in providing the oncolo...
ESMO in Biological News

European Multidisciplinary Conference on Thoracic Oncology

...resenters of the studies, both in presence and remotely. Please contact the esmo Communication Dept. at media@esmo.org to already find out about the preli...newsroom/events/ and send the Complimentary Media Registration form to the esmo Communication Department. Accommodation For hotel reservation, pleas...

New treatment approach promising for lymphoma patients in the developing world

...patients with aggressive non-Hodgkin's lymphoma in the developing world might benefit from a modified chemotherapy regimen, researchers say. At the esmo Conference Lugano (ECLU) organized by the European Society for Medical Oncology, a group headed by Prof. Hamdy Azim from Cairo University reports that...

Treatment delays result in poor outcomes for men with breast cancer

...lthough most breast cancer patients are women, men make up roughly 1% of cases, Dr. Marina Garassino from the Orion Collaborative Group reports at the esmo Conference Lugano (ECLU), organized by the European Society for Medical Oncology. Her group conducted a retrospective analysis of 146 men with inv...

Counting tumor cells in blood predicts treatment benefit in prostate cancer

...am of patients with castration-resistant prostate cancer can accurately predict how well they are responding to treatment, new results show. At the esmo Conference Lugano (ECLU) organized by the European Society for Medical Oncology, researchers showed that changes in the number of circulating tumor ce...

First European Lung Cancer Conference

...for Medical Oncology (ESMO), the European Lung Cancer Conference will be held biennially, alternating with the World Conference on Lung Cancer and the esmo chest tumors conference. The event will gather top multidisciplinary experts to provide the audience (European and worldwide) with state-of-the-art ed...

ESMO International Symposium on Immunology

...cs in the field of tumor immunology and immunotherapy will be discussed by international experts to the benefit of young cancer specialists during the esmo International Symposium (EIS) on Immunology. Immunology has come to stay in oncology: this EIS symposium will offer a comprehensive overview of the in...
ESMO in Biological Technology

33rd ESMO Congress in Stockholm, 12-16 September 2008

LUGANO, Switzerland, September 5 /PRNewswire/ -- The 33rd ESMO Congress in Stockholm, the premier European congress in Oncology, serves as a meeting place for medical oncologists, as well as a focal point to exchange ideas with colleagues from other disciplines. The Congress Centre will be t...

Palonosetron Warrants Adequate Caloric Intake in Oncology Patients Receiving High Emetogenic Chemotherapy

...s adequate caloric intake in oncology patients. Data presented today at the esmo Symposium on Cancer and Nutrition in Zurich, Switzerland New data presented today at the esmo (European Society of Medical Oncology) Symposium on Cancer and Nutrition in...
Other Tags
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. 21, ... Ebola cases in Dallas. But, mental health specialists say overblown ... President Barack Obama on Friday appointed an Ebola "czar" to ... two Dallas nurses who cared for a Liberian man who ... But the U.S. cases are miniscule in the context ...
(Date:10/22/2014)... With the Affordable Care Act (ACA) open enrollment ... Institutes for Research (AIR) finds that three out of four ... but 42 percent say they are not likely or only ... for coverage. , The AIR survey found wide gaps in ... calculate correctly how much they owe for a routine doctor’s ...
(Date:10/22/2014)... 22, 2014 Although there are only 24 hours ... many people who have trouble finding time within their busy schedules ... for long periods of time to get in shape. Here are ... on the go. , Change Up Your Commute , Consider ... to add some exercise into your daily routine. If you must ...
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. 21, 2014 ... are only about half as likely as white women to ... indicates, and the racial disparity persists even when donor eggs ... white patients became pregnant after IVF, compared to about 17 ... cycles over two years to tease out the impact of ...
(Date:10/22/2014)... HealthDay Reporter , MONDAY, Oct. 20, 2014 ... guidelines for health workers treating Ebola patients, now requiring full ... respirator at all times. The U.S. Centers for Disease ... two Dallas nurses contracted Ebola while caring for the first ... Eric Duncan. Nina Pham is currently being treated for her ...
Breaking Medicine News(10 mins):Health News:Ebola Anxiety: A Bigger Threat Now Than the Virus Itself 2Health News:Ebola Anxiety: A Bigger Threat Now Than the Virus Itself 3Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 2Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 3Health News:Many Americans Fail to Ask Basic Questions Before Signing Up for Health Insurance, National Survey Finds 4Health News:HealthGuideMD Presents Ways to Improve Your Exercise and Fitness 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 3Health News:CDC Tightens Rules on Caring for Ebola Patients 2Health News:CDC Tightens Rules on Caring for Ebola Patients 3
(Date:10/15/2014)... The German Gauß-Allianz has admitted Johannes Gutenberg University ... the Rhineland-Palatinate science hub continues to maintain a ... computing. , "The acceptance of Johannes Gutenberg ... Gauß-Allianz is a milestone in the national and ... support. The state of Rhineland-Palatinate can be proud ...
(Date:10/15/2014)... SHELTON, Conn. , Oct. 15, 2014 NXT-ID, Inc. ... a biometric authentication company focused on the growing mobile commerce market ... NASDAQ MarketSite in Times Square on Monday October 13 th . ... with CTO David Tunnel and angel investor Mr. ... Gino Pereira , CEO of NXT-ID thanked his investors and employees ...
(Date:10/14/2014)... Like discriminating thieves, prostate cancer tumors scavenge and hoard ... But such avarice may be a fatal weakness. ... to kill prostate cancer cells by delivering a trove ... the diseased cells brimming with the mineral, leaving non-cancer ... drugs already commercially available for other uses, could soon ...
Breaking Biology News(10 mins):Johannes Gutenberg University Mainz joins Germany's Gauss-Allianz as a full member 2Johannes Gutenberg University Mainz joins Germany's Gauss-Allianz as a full member 3Photo Release: NXT-ID Inc. Rings Opening Bell of the NASDAQ Stock Market October 13th 2Photo Release: NXT-ID Inc. Rings Opening Bell of the NASDAQ Stock Market October 13th 3Prostate cancer's penchant for copper may be a fatal flaw 2
Other Contents